Table 1: General characteristics of patients subjected to aortic valve
replacement.
|
|
|||
|
PARAMETER |
DOBUTAMINE |
LEVOSIMEDAN |
‘P’ value |
|
Age (years) |
55.2 ± 14.5 |
59.6 ± 11.7 |
0.33 * |
|
Male |
10 (33%) |
7 (23%) |
0.39 |
|
Weight (Kg) |
68.15 ± 12.7 |
68.14 ± 11.7 |
0.99 |
|
BMI (Kg/m2) |
1.73 ± 0.24 |
1.71 ± 0.18 |
0.64 * |
|
CEC Time (min) |
105.6 ± 33.1 |
118.9 ± 54.9 |
0.54 * |
|
PAo Time (min) |
73.9 ± 17.1 |
80.4 ± 25 |
0.59 * |
|
Dose (gammas) |
4.05 ± 1.05 |
0.16 ± 0.05 |
NA |
*Student T-test of
independent samples.